Clinical Trials Logo

Clinical Trial Summary

Two common corticosteroids used for trigger finger treatment are betamethasone and methylprednisolone. Both injections are effective in treating trigger finger and the decision of which to use in treatment is currently a matter of the current practice and physician preference. The goal through this randomized trial is to see whether there is a difference between these two corticosteroids in inducing flare reactions and if there are any differences in the peak level of pain and their duration. Findings indicating a statistically significant difference in the incidence and/or intensity of the flare reactions would be clinically significant and would be evidence supporting the switch of current practice to one corticosteroid over the other.


Clinical Trial Description

Corticosteroid injections are effective non-surgical approach to treating trigger finger (stenosing tenosynovitis) with success rates reported as high as 92% after just one injection [1]. Among their side effects is a post-injection flare of increased pain that is attributed to crystal-induced synovitis. Reports of these flares in the literature have been rare. Recent evidence their incidence can be as high as 33%. The investigators feel it is a more common clinical issue than traditionally reported and it would be beneficial to control and reduce their incidence if possible. Two common corticosteroids used for trigger finger treatment are betamethasone and methylprednisolone. Both injections are effective in treating trigger finger and the decision of which to use in treatment is currently a matter of the current practice and physician preference. There is no literature comparing the side effects, specifically flare reactions between these two treatments. The goal through this randomized trial is to see whether there is a difference between these two corticosteroids in inducing flare reactions and if there are any differences in the peak level of pain and their duration. This is a double-blinded randomized trial enrolling patients into one of the two treatment groups. The volume of the doses will be standardized to 1 cc of either methylprednisolone (40 mg) or betamethasone (6 mg). Patients, who meet the inclusion criteria, will be instructed to complete a visual analog scale (VAS) of their pain (1-10) prior to the injection, during the injection and once a day for the following 7 days after the injection. The investigators estimate that a minimum of 30 patients in each group will be needed to achieve a minimum of 80% power and 0.05 significance. The incidence, intensity, time to peak and time to resolution of the flare reactions (defined as a 2-point increase from pre-injection pain) will be assessed and compared between the two groups. Findings indicating a statistically significant difference in the incidence and/or intensity of the flare reactions would be clinically significant and would be evidence supporting the switch of current practice to one corticosteroid over the other. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04900220
Study type Interventional
Source West Virginia University
Contact
Status Completed
Phase Phase 4
Start date September 15, 2021
Completion date April 10, 2023

See also
  Status Clinical Trial Phase
Completed NCT04094389 - Comparison of Trigger Finger Orthotic Wearing Schedules N/A
Completed NCT05435950 - Clinical Investigation on Safety, Performance and Effectiveness of Sono-instruments N/A
Completed NCT06401473 - Using the Gate Control Theory of Pain to Decrease Pain During Trigger Finger Corticosteroid Injections N/A
Completed NCT04354415 - Tourniquet vs. No Tourniquet for Carpal Tunnel and Trigger Finger Release N/A
Recruiting NCT06296017 - Effectiveness of Conservative Interventions in the Treatment of Trigger Finger N/A
Completed NCT06288685 - Percutaneous Trigger Finger Release Concomitant Steroid Injection Versus Percutaneous Trigger Finger Release Alone Phase 3
Completed NCT06382623 - Efficacies of Different Managements in Patients With Trigger Finger
Active, not recruiting NCT04568993 - The TriggerHappy Trial N/A
Completed NCT04023695 - Trigger Finger Corticosteroid Injection With and Without Local Anesthetic Phase 4
Recruiting NCT04645303 - Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger Early Phase 1
Recruiting NCT03156829 - Effectiveness of Cortisone Injection and Splinting for Trigger Finger Phase 4
Completed NCT01987115 - Comparison of Fascial Manipulation With Traditional Physiotherapy for the Treatment of Trigger Fingers N/A
Completed NCT01950793 - A Comparison Between Sonoguided Injection Corticosteroid and Hyaluronic Acid Injection in Treatment of Trigger Finger N/A
Completed NCT02196233 - Surgical Treatment of Adult Trigger Finger
Recruiting NCT04675892 - Resection of Flexor Digitorum Superficialis Tendon for Severe Trigger Fingers N/A
Terminated NCT05082480 - Evaluate the Effectiveness of Crosslinked HA on the Adhesion Preventing After Trigger Finger Release Surgery N/A
Recruiting NCT05045157 - Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders N/A
Active, not recruiting NCT01886157 - Treatment of Trigger Finger With Steroid Injection Versus Steroid Injection and Splinting N/A
Recruiting NCT00951236 - Study Comparing One Versus Two Cortisone Injections for Trigger Finger N/A
Withdrawn NCT04855942 - Focused Extracorporeal Shock Wave Therapy (ESWT) Versus Traditional Physiotherapy in the Treatment of Trigger Finger N/A